药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Vilazodone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vilazodone.
Potassium cation
Esmirtazapine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Esmirtazapine.
Potassium cation
Saredutant
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Saredutant.
Potassium cation
Agomelatine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Agomelatine.
Potassium cation
Dextofisopam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dextofisopam.
Potassium cation
Adipiplon
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Adipiplon.
Potassium cation
Ocinaplon
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ocinaplon.
Potassium cation
Tramiprosate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tramiprosate.
Potassium cation
Deramciclane
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Deramciclane.
Potassium cation
Clomethiazole
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clomethiazole.
Potassium cation
Remacemide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Remacemide.
Potassium cation
Dotarizine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dotarizine.
Potassium cation
Amisulpride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amisulpride.
Potassium cation
Tolperisone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tolperisone.
Potassium cation
Lacosamide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lacosamide.
Potassium cation
Asenapine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Asenapine.
Potassium cation
Pizotifen
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pizotifen.
Potassium cation
Sertindole
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sertindole.
Potassium cation
YKP-1358
The risk or severity of adverse effects can be increased when Cannabidiol is combined with YKP-1358.
Potassium cation
Lumateperone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lumateperone.